Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics, Inc. (LXEO) Capital Expenditures (2022 - 2023)

Lexeo Therapeutics' Capital Expenditures history spans 2 years, with the latest figure at $11000.0 for Q3 2023.

  • For Q3 2023, Capital Expenditures changed N/A year-over-year to $11000.0; the TTM value through Dec 2023 reached $50000.0, changed N/A, while the annual FY2023 figure was $50000.0, 92.56% down from the prior year.
  • Capital Expenditures for Q3 2023 was $11000.0 at Lexeo Therapeutics, down from $27000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $666000.0 in Q4 2022 and bottomed at $11000.0 in Q3 2023.